HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.

AbstractBACKGROUND:
Patients with negative anti-Helicobacter pylori antibody titer and high pepsinogen (PG) level (group A) are regarded as having a low risk for gastric cancer. However, gastric cancer cases are occasionally observed in this group. We aimed to elucidate the clinical features of gastric neoplasm in group A patients and reviewed advanced methods for mass screening.
MATERIALS AND METHODS:
A total of 271 gastric epithelial neoplasm patients were enrolled. We classified them according to the H. pylori-PG system and determined the number of patients in each group. After excluding true H. pylori-negative cases from group A (group A'), we examined the differences between group A' and group non-A.
RESULTS:
Group A included 30 (11%) patients, and only three of these were true negative for H. pylori. All patients in group A' (n = 27) exhibited endoscopic atrophy in the gastric corpus. Serologically, these patients showed low gastrin, low PG II and high PG I/II ratio, indicative of post-eradication. Histologically, 24 (89%) of these had little inflammation, and 26 (96%) were negative for H. pylori by immunohistochemistry. No difference was observed in the incidence of metachronous gastric tumors between group A' and group non-A. The discriminant function using gastrin and PGs could distinguish these 27 patients from true H. pylori-negative controls with 85% sensitivity and 84% specificity.
CONCLUSIONS:
Group A included a certain number of patients with atrophic gastritis who were potentially at risk of gastric neoplasm development. Although evaluation of corpus atrophy is necessary for the identification of these patients, the discriminant function may be useful.
AuthorsTomoyuki Boda, Masanori Ito, Masaharu Yoshihara, Yoko Kitamura, Taiji Matsuo, Shiro Oka, Shinji Tanaka, Kazuaki Chayama
JournalHelicobacter (Helicobacter) Vol. 19 Issue 1 Pg. 1-8 (Feb 2014) ISSN: 1523-5378 [Electronic] England
PMID24215601 (Publication Type: Evaluation Study, Journal Article)
Copyright© 2013 John Wiley & Sons Ltd.
Chemical References
  • Biomarkers, Tumor
  • Pepsinogen A
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Atrophy (pathology)
  • Biomarkers, Tumor (blood)
  • Endoscopy, Gastrointestinal
  • Female
  • Gastric Mucosa (pathology)
  • Helicobacter Infections (complications)
  • Helicobacter pylori (isolation & purification)
  • Histocytochemistry
  • Humans
  • Immunohistochemistry
  • Male
  • Mass Screening (methods)
  • Microscopy
  • Middle Aged
  • Pepsinogen A (blood)
  • Risk Assessment
  • Sensitivity and Specificity
  • Stomach Neoplasms (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: